Source: Revista Brasileira de Terapia Intensiva. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, ANTIBIÓTICOS, UNIDADES DE TERAPIA INTENSIVA, PEDIATRIA
ABNT
PIRES, Frederico Ribeiro et al. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens?. Revista Brasileira de Terapia Intensiva, v. 32, n. 3 p. 391-397, 2020Tradução . . Disponível em: https://doi.org/10.5935/0103-507X.20200067. Acesso em: 16 nov. 2024.APA
Pires, F. R., Paula, S. I. de, Delgado, A. F., Carvalho, W. B. de, Duarte, N. J. C., Morales Júnior, R., & Santos, S. R. C. J. (2020). Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? Revista Brasileira de Terapia Intensiva, 32( 3 p. 391-397). doi:10.5935/0103-507X.20200067NLM
Pires FR, Paula SI de, Delgado AF, Carvalho WB de, Duarte NJC, Morales Júnior R, Santos SRCJ. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? [Internet]. Revista Brasileira de Terapia Intensiva. 2020 ; 32( 3 p. 391-397):[citado 2024 nov. 16 ] Available from: https://doi.org/10.5935/0103-507X.20200067Vancouver
Pires FR, Paula SI de, Delgado AF, Carvalho WB de, Duarte NJC, Morales Júnior R, Santos SRCJ. Does vancomycin administered at an empirical dose ensure coverage of pediatric patients against grampositive pathogens? [Internet]. Revista Brasileira de Terapia Intensiva. 2020 ; 32( 3 p. 391-397):[citado 2024 nov. 16 ] Available from: https://doi.org/10.5935/0103-507X.20200067